Read + Share
Kalal CR, Gupta P. Rifaximin and the DCA-serotonin axis in cirrhotic portal hypertension: how much
of the benefit is bile-acid specific? J Hepatol 2026 Jun 20:S0168-8278(26)02650-4. doi: 10.1016/j.jhep.2026.
PMID: 42323024
|
 |
|
Kalal CR, Gupta P. Rifaximin and the DCA-serotonin axis in cirrhotic portal hypertension: how much
of the benefit is bile-acid specific? J Hepatol 2026 Jun 20:S0168-8278(26)02650-4. doi: 10.1016/j.jhep.2026.
PMID: 42323024
|
|
|
|